Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Malkin

Showing results (81-90 of 270) with videos related to

Pageof 27
Sort By:
Journal of Clinical Medicine|November 27, 2024
Characterisation of Paediatric Neuroblastic Tumours by Quantitative Structural and Diffusion-Weighted MRIDomenica Tambasco, Margalit Zlotnik, Sayali Joshi, et al.
Cancer Research|August 17, 2005
A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastomaBikul Das, Herman Yeger, Rika Tsuchida, et al.
Journal of Medical Genetics|February 14, 2018
Evidence for genetic anticipation in vonHippel-Lindau syndromeLaura Aronoff, David Malkin, Kalene van Engelen, et al.
Pediatric Blood & Cancer|March 31, 2021
Tumor surveillance for children and adolescents with cancer predisposition syndromes: The psychosocial impact reported by adolescents and caregiversKalene van Engelen, Maru Barrera, Jonathan D Wasserman, et al.
Journal of Pediatric Hematology/Oncology|November 27, 2013
Metachronous neuroblastoma in an infant with germline translocation resulting in partial trisomy 2p: a role for ALK?Daniel A Morgenstern, Shui Yen Soh, Dimitri J Stavropoulos, et al.
Annual Review of Genomics and Human Genetics|August 31, 2022
Mosaicism in Tumor Suppressor Gene Syndromes: Prevalence, Diagnostic Strategies, and Transmission RiskJillian L Chen, David T Miller, Laura S Schmidt, et al.
JCO Precision Oncology|February 1, 2022
Parents', Health Care Professionals', and Scientists' Experiences of a Precision Medicine Pilot Trial for Patients With High-Risk Childhood Cancer: A Qualitative StudyJanine Vetsch, Claire E Wakefield, Emily Duve, et al.
Pediatric Blood & Cancer|December 6, 2016
Societal preferences in the treatment of pediatric medulloblastoma: Balancing risk of death and quality of lifeAmir Khakban, Tima Mohammadi, Larry D Lynd, et al.
Pediatric Hematology and Oncology|June 19, 2004
Characterization of bone marrow stromal abnormalities in a patient with constitutional trisomy 8 mosaicism and myelodysplastic syndromeAru Narendran, Lindsay M Hawkins, Hooman Ganjavi, et al.
Journal of Neuro-Oncology|January 5, 2019
PPAR and GST polymorphisms may predict changes in intellectual functioning in medulloblastoma survivorsAdeoye Oyefiade, Lauren Erdman, Anna Goldenberg, et al.
Pageof 27

Showing results (81-90 of 270) with videos related to

Sort By:
Pageof 27
Journal of Clinical Medicine|November 27, 2024
Characterisation of Paediatric Neuroblastic Tumours by Quantitative Structural and Diffusion-Weighted MRIDomenica Tambasco, Margalit Zlotnik, Sayali Joshi, et al.
Cancer Research|August 17, 2005
A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastomaBikul Das, Herman Yeger, Rika Tsuchida, et al.
Journal of Medical Genetics|February 14, 2018
Evidence for genetic anticipation in vonHippel-Lindau syndromeLaura Aronoff, David Malkin, Kalene van Engelen, et al.
Pediatric Blood & Cancer|March 31, 2021
Tumor surveillance for children and adolescents with cancer predisposition syndromes: The psychosocial impact reported by adolescents and caregiversKalene van Engelen, Maru Barrera, Jonathan D Wasserman, et al.
Journal of Pediatric Hematology/Oncology|November 27, 2013
Metachronous neuroblastoma in an infant with germline translocation resulting in partial trisomy 2p: a role for ALK?Daniel A Morgenstern, Shui Yen Soh, Dimitri J Stavropoulos, et al.
Annual Review of Genomics and Human Genetics|August 31, 2022
Mosaicism in Tumor Suppressor Gene Syndromes: Prevalence, Diagnostic Strategies, and Transmission RiskJillian L Chen, David T Miller, Laura S Schmidt, et al.
JCO Precision Oncology|February 1, 2022
Parents', Health Care Professionals', and Scientists' Experiences of a Precision Medicine Pilot Trial for Patients With High-Risk Childhood Cancer: A Qualitative StudyJanine Vetsch, Claire E Wakefield, Emily Duve, et al.
Pediatric Blood & Cancer|December 6, 2016
Societal preferences in the treatment of pediatric medulloblastoma: Balancing risk of death and quality of lifeAmir Khakban, Tima Mohammadi, Larry D Lynd, et al.
Pediatric Hematology and Oncology|June 19, 2004
Characterization of bone marrow stromal abnormalities in a patient with constitutional trisomy 8 mosaicism and myelodysplastic syndromeAru Narendran, Lindsay M Hawkins, Hooman Ganjavi, et al.
Journal of Neuro-Oncology|January 5, 2019
PPAR and GST polymorphisms may predict changes in intellectual functioning in medulloblastoma survivorsAdeoye Oyefiade, Lauren Erdman, Anna Goldenberg, et al.
Pageof 27